Research of Tongxinluo regulates and controls the expressions of p38 MAPK and extracellular ;matrix deposition
仝宇,高彦彬,王晓磊,田年秀,耿建国
DOI: https://doi.org/10.3969/j.issn.1674-1749.2017.02.004
2017-01-01
Abstract:Objective To investigate the influence of Tongxinluo( TXL) on renal tissue p38 MAPK signaling pathway, transforming growth factor β1 ( TGF-β1 ) , extracellular matrix FN and Col-Ⅳ in spontaneous T2DM KK-Ay mice, and to explore the mechanism of TXL inhibiting renal fibrosis in diabetic nephropathy. Methods 45 spontaneous T2DM KK-Ay mice were used to induced diabetic nephropathy models, and randomly divided into model group, TXL group and western medicine group, 15 mice in each group. 15 C57BL/6J mice were chosen as the normal group. Diabetic nephropathy models were treated for 12 weeks. Blood glucose( FBG) , body weight( BW) , kidney weight( KW) , index of kidney weight= KW/BW, renal function ( Scr, Urea ) as well as urinary micro-albumin biochemical parameters ( mALB ) were detected;TGF-β1, p38, P-p38, FN, Col-Ⅳ were detected with Western blot. Results Comparing with the normal group, the expressions of FBG, urinary micro-albumin, Scr, Urea were significantly increased (P<0. 05), and the expressions of TGF-β1, P-p38, FN, Col-Ⅳ were increased(P<0. 05). On the other hand, comparing with the model group, the expressions of FBG, urinary micro-albumin, Scr, Urea were decreased in both administration groups(P<0. 05). However, the expression of FBG stayed unchanged (P<0.05). Moreover, there were no differences in all groups in the expressions of p38(P<0. 05). Conclusion TXL had no effect on blood glucose, but it could reduce the expressions of TGF-β1, inhibit the phosphorylation of p38 and affect extracellular matrix deposition, which might become one of the mechanisms for its treatment of DN.